Christopher Richards - Plant Health Insider

PHC -- UK Stock  

GBp 25.20  2.00  8.62%

Non-Executive Independent Chairman of the Board

Dr. Christopher G. J. Richards, Ph.D. was appointed as Executive Chairman of the Board, Interim Chief Executive Officer of Plant Health Care Plc, effective 30 November 2016. He joined the Group as nonexecutive Chairman on 1 August 2012, has a wealth of experience in the agriculture industry. A UK citizen, he spent 20 years at Syngenta and its predecessor companies, in roles spanning strategic product management and front line management in South America, Europe and Asia. In 2003, he was appointed CEO of Arysta LifeScience and led its transformation into a global agrochemical company with sales above 1.6 billion. He was NonExecutive Chairman of Arysta from 2010 until February 2015. His current portfolio includes board positions with Dechra plc, an international specialist veterinary pharmaceuticals business, and Cibus Global, a precision gene editing company focused on nontransgenic breeding and nontransgenic crop development he is also Chairman of Oxitec Ltd., a pioneer in controlling insects that spread disease and damage crops. To take a more active role in developing strategy and investor relations, He will become Executive Chairman on 1 April 2015.
Age: 59  Chairman Since 2016  Ph.D    
919-926-1600  http://www.planthealthcare.com
Richards joined Arysta LifeScience as Chief Operating Officer in 2003 and was Chief Executive Officer from 2004 to 2010. Under his leadership, Arysta LifeScience became one of the fastestgrowing companies in the agrochemical industry. Arysta LifeScience was acquired by Permira Funds in 2008.Dr. Richards previously worked in international management roles at Syngenta Crop Protection and its predecessor companies, Zeneca and ICI. He began his career at the UK Ministry of Agriculture, Fisheries and Food, having been awarded a doctorate in animal ecology from St. John?s College, Oxford.

Management Efficiency

The company has return on total asset (ROA) of (23.2) % which means that it has lost $23.2 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (41.53) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 8 K in total debt. Plant Health Care plc has Current Ratio of 3.44 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 2 records

CHAIRMAN Since

Charles SinclairAssociated British Foods plc
2009
Peter HadsleyChaplinM P Evans Group plc
2010

Entity Summary

Plant Health Care plc, together with its subsidiaries, provides patent-protected biological products for the agriculture industry in the Americas, Mexico, and rest of world. Plant Health Care plc was founded in 1995 and is based in Manchester, the United Kingdom. Plant Health operates under Agribusiness Agriculture And Fishing classification in UK and traded on London Stock Exchange. It employs 37 people.Plant Health Care plc (PHC) is traded on London Stock Exchange in UK. It is located in 1 Scott Place and employs 37 people.

Plant Health Care Leadership Team

Andrew Wood, Executive
William Lewis, Director
Christopher Richards, Chairman, Ph.D
Richard Webb, Director, Ph.D
Michael Higgins, Director
Paul Schmidt, CEO
James EdeGolightly, Director, CFA

Stock Performance Indicators

Did you try this?

Run Equity Analysis Now
   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Equity Analysis

Trending Equities

Currently Active Assets on Macroaxis
OZL   
Purchased over 100 shares of
over a week ago
Traded for 10.44
FBU   
Purchased over 300 shares of
over a week ago
Traded for 6.24
JBH   
Purchased over 70 shares of
over a week ago
Traded for 23.42
GNC   
Purchased over 200 shares of
over a week ago
Traded for 8.1
SBM   
Purchased over 400 shares of
over a week ago
Traded for 4.74
Additionally take a look at Your Equity Center. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.